These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 6361922)

  • 1. [Progressive systemic sclerosis. A diagnostic problem].
    Posada de la Paz M; Martínez L de Letona J; Masa Vázquez C; Ruiz Galiana J; Pérez Alvarez R; Díez García F; Pérez Maestu R
    Rev Clin Esp; 1983 Sep; 170(6):237-41. PubMed ID: 6361922
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluating microangiopathy in systemic sclerosis: what have we learnt and what is left to discover?
    Cutolo M; Sulli A; Smith V
    Expert Rev Clin Immunol; 2011 Jul; 7(4):395-7. PubMed ID: 21790279
    [No Abstract]   [Full Text] [Related]  

  • 3. The pathophysiology of the fibrosis in scleroderma skin.
    Fleischmajer R; Perlish JS
    Prog Clin Biol Res; 1984; 154():381-404. PubMed ID: 6382305
    [No Abstract]   [Full Text] [Related]  

  • 4. [Various aspects of the pathogenesis of systemic scleroderma and the role of microcirculation in the morphogenesis of joint changes in the diseases].
    Rusakova MS
    Vopr Revm; 1982; (2):68-71. PubMed ID: 7113091
    [No Abstract]   [Full Text] [Related]  

  • 5. The vascular, inflammatory, and fibrotic components in scleroderma skin.
    Fleischmajer R; Perlish JS
    Monogr Pathol; 1983; 24():40-54. PubMed ID: 6350857
    [No Abstract]   [Full Text] [Related]  

  • 6. [About "Multiple sclerosis and autoimmune diseases" ].
    Spadaro A; Valesini G
    Reumatismo; 2002; 54(1):68. PubMed ID: 12089618
    [No Abstract]   [Full Text] [Related]  

  • 7. [A case of progressive systemic sclerosis (PSS) without scleroderma].
    Nagase T; Okudaira H; Komuro K; Yoshida K; Moroi Y; Mitamura T; Miyamoto T
    Ryumachi; 1985 Sep; 25(4):292-6. PubMed ID: 4081910
    [No Abstract]   [Full Text] [Related]  

  • 8. [Problems and observations on progressive systemic scleroderma].
    Gräfenstein K
    Z Gesamte Inn Med; 1985 Jul; 40(14):413-7. PubMed ID: 4049977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis.
    LeRoy EC; Black C; Fleischmajer R; Jablonska S; Krieg T; Medsger TA; Rowell N; Wollheim F
    J Rheumatol; 1988 Feb; 15(2):202-5. PubMed ID: 3361530
    [No Abstract]   [Full Text] [Related]  

  • 10. [Demonstration of antinuclear antibodies in the epidermis of patients with progressive systemic sclerosis, generalized lupus erythematosus and dermatomyositis].
    Lamas Robles C; Mejía Arreguín S; Orozco Medina JH; González Mendoza A
    Rev Invest Clin; 1984; 36(2):115-9. PubMed ID: 6385174
    [No Abstract]   [Full Text] [Related]  

  • 11. [Electron microscopy study of pathological collagen fibril formation in systemic scleroderma].
    Ptashekas RS; Vaĭtkene DI
    Arkh Patol; 1984; 46(7):49-54. PubMed ID: 6477175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Case report: progressive systemic sclerosis-like syndrome after bone marrow transplantation. Clinical, immunologic, and pathologic findings.
    Herzog P; Clements PJ; Roberts NK; Furst DE; Johnson CE; Feig SA
    J Rheumatol; 1980; 7(1):56-64. PubMed ID: 6986468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [How to recognize scleroderma].
    Francès C; Ayoub N; Barete S
    Rev Prat; 2002 Nov; 52(17):1884-90. PubMed ID: 12532864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Lung impairment in systemic sclerosis].
    Knoop H; Arinir U; Kreuter A; Walther JW; Schultze-Werninghaus G; Rohde G
    Pneumologie; 2009 Sep; 63(9):497-507. PubMed ID: 19708006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progressive systemic sclerosis. Diagnosis at the age of 4 years.
    Velayos EE; Cohen BS
    Am J Dis Child; 1972 Jan; 123(1):57-60. PubMed ID: 5010554
    [No Abstract]   [Full Text] [Related]  

  • 16. [Early diagnosis of progressive systemic sclerosis: the role of oro-facial phenomena].
    Scardina GA; Mazzullo M; Messina P
    Minerva Stomatol; 2002; 51(7-8):311-7. PubMed ID: 12434126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Scleroderma. A model for fibrosis.
    Fleischmajer R; Perlish JS; Duncan M
    Arch Dermatol; 1983 Dec; 119(12):957-62. PubMed ID: 6360053
    [No Abstract]   [Full Text] [Related]  

  • 18. [Lingual involvement in progressive systemic sclerosis].
    Pila Pérez R; Pila Peláez R; Pila Peláez M; Guerra Rodríguez C; Rojas Casanova C
    Acta Otorrinolaringol Esp; 2000; 51(8):740-2. PubMed ID: 11270113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New developments in the pathogenesis of systemic sclerosis.
    Sakkas LI
    Autoimmunity; 2005 Mar; 38(2):113-6. PubMed ID: 16040330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topics in clinical medicine. Clinical synopsis of scleroderma, simulator of other diseases.
    Tumulty PA
    Johns Hopkins Med J; 1968 Apr; 122(4):236-46. PubMed ID: 5648181
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.